Advertisement

PharmacoEconomics

, Volume 2, Issue 2, pp 153–162 | Cite as

Discounting of Health Benefits in the Pharmacoeconomic Analysis of Drug Therapies

An Issue for Debate?
  • Douglas Coyle
  • Keith Tolley
Review Article

Summary

In most economic evaluations. future monetary costs and benefits and future health benefits are discounted at the same rate. The purpose of this article is to question such current practice. The primary reason behind discounting costs and benefits is to allow for individuals’ preferences over the timing of such events, i.e. to represent social time preference. We argue that the social time preference rate for health benefits is unlikely to be the same as that for monetary costs and benefits. The results of a sensitivity analysis of pharmacoeconomic analyses of drug treatments for hypertension illustrate how the choice of discount rate can affect the conclusions. As no definite conclusions can be drawn regarding the magnitude of the discount rate for health benefits, we recommend that analysts conduct sensitivity analyses employing differential discount rates for health benefits as well as monetary costs and benefits.

Keywords

Health Benefit Discount Rate Marginal Utility Time Preference Pharmacoeconomic Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bush JW, Chen MM, Patrick DL. Health status index in cost-effectiveness analysis: analysis of PKU program. In Berg RL (Ed.) Health status indexes, Hospital Research and Educational Trust, Chicago, 1973Google Scholar
  2. Cairns J. Health, wealth and time preference. Health Economics Research Unit Discussion Paper 07/91. University of Aberdeen, 1991Google Scholar
  3. Cairns J. Discounting and health benefits: another perspective. Health Economics 1(1): 76–79, 1992PubMedCrossRefGoogle Scholar
  4. Department of Health. Health of the nation. HMSO, London, 1991Google Scholar
  5. Drummond MF. Studies in economic appraisal in health care. Oxford University Press, Oxford. 1981Google Scholar
  6. Drummond MF, Coyle D. Assessing the economic value of antihypertensive medicines. Journal of Human Hypertension. in press, 1992Google Scholar
  7. Drummond MF, Ludbrook A, Lowson K, Steele A. Studies in economic appraisal in health care. Vol. 2. Oxford University Press, Oxford, 1986Google Scholar
  8. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford, 1987Google Scholar
  9. Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics 1: 20–31. 1992PubMedCrossRefGoogle Scholar
  10. Fuchs VR. Time preference and health: an exploratory study. In Fuchs VR (Ed.) Economic aspects of health. University of Chicago Press, Chicago. 1982Google Scholar
  11. Goodin LE. Discounting discounting. Journal of Public Policy 2: 53–72, 1982CrossRefGoogle Scholar
  12. Grossman M. The demand for health: a theoretical and empirical investigation. NBER Occasional Paper 119, Columbia University Press, New York. 1972Google Scholar
  13. Horowitz JK, Carson RT. Discounting statistical lives. Journal of Risk and Uncertainty 3: 403–413, 1990CrossRefGoogle Scholar
  14. Keeler EB, Cretin J. Discounting of life-saving and other nonmonetary effects. Management Science 29: 300–306, 1983CrossRefGoogle Scholar
  15. Krahn M, Gafni A. Discounting in the economic evaluation of health care interventions: from practice. to theory, to practice. Centre for Health Economics and Policy Analysis Working Paper 92/2. MacMaster University. 1992Google Scholar
  16. Marglin SA. The social rate of discount and the optimal rate of investment. Quarterly Journal of Economics 77: 95–111, 1963CrossRefGoogle Scholar
  17. Mooney GH. Economics. medicine and health care. Harvester Wheatsheaf, London. 1986Google Scholar
  18. Moore MJ, Viscusi WK. Models for estimating discount rates for long-term health risks using labor market data. Journal of Risk and Uncertainty 3: 381–401. 1990CrossRefGoogle Scholar
  19. Olsen JA. Is the time preference rate for health different? Paper presented at the Second World Congress on Health Economics. Zurich. 1990Google Scholar
  20. Parfit D. Reasons and persons, Clarendon Press, London, 1984Google Scholar
  21. Parsonage M, Neuberger H. Discounting and health benefits. Health Economics 1(1): 71–76, 1992PubMedCrossRefGoogle Scholar
  22. Pigou AC. The economics of welfare. MacMillan, London. 1920Google Scholar
  23. Ramsey FP. A mathematical theory of saving. Economic Journal 38: 543–559, 1928CrossRefGoogle Scholar
  24. Rawls J. A theory of justice. Harvard University Press, Cambridge, 1971Google Scholar
  25. Shepard DS. Thompson MS. First principles of cost-effectiveness in health. Public Health Reports 6: 535–543, 1979Google Scholar
  26. Sugden R. On the political economy of social discount rates. In AJ Culyer (Ed.) Economic policies and social goals: aspects of public choice, Martin Robertson, London. 1974Google Scholar
  27. United Nations. Demographic Yearbook 1987. United Nations, New York. 1989Google Scholar
  28. Warner KE, Luce BR. Cost-benefit and cost-effectiveness analysis in health care: principles. practice and potential. Health Administration Press, Ann Arbor, Michigan, 1982Google Scholar
  29. Weinstein MC. Estrogen use in postmenopausal women — costs, risks and benefits. New England Journal of Medicine 303: 308–316. 1980PubMedCrossRefGoogle Scholar
  30. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296: 716–721, 1977PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1992

Authors and Affiliations

  • Douglas Coyle
    • 1
  • Keith Tolley
    • 1
  1. 1.Centre for Health EconomicsUniversity of YorkYorkEngland

Personalised recommendations